MAZORELVIMAB

UNII:	YRJ2INY46N
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	MAZORELVIMAB
GSRS Full Record:	YRJ2INY46N i

2419087-89-9
CTB-012
CTB012
Immunoglobulin G1, anti-(rabies lyssavirus spike glycoprotein G) (human-Mus musculus clone 2G11 γ1-chain), disulfide with human-Mus musculus clone 2G11 kchain, dimer
MAZORELVIMAB [USAN]
Mazorelvimab [WHO-DD]
SYN-023 COMPONENT CTB-012
SYN023 COMPONENT CTB012
immunoglobulin G1-kappa, anti-[rabies lyssavirus (rabies virus, RABV) spike glycoprotein G], monoclonal antibody; gamma1 heavy chain (1-450) [VH (Homo sapiens IGHV3-48*03 (85.7%) -(IGHD) -IGHJ4*01 (92.3%) L123>M (115), CDRIMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*01 (100%), G1m17,1 (CH1 K120 (217) (121-218), hinge 1-15 (219-233), CH2 (234-343), CH3 D12 (359), L14 (361) (344-448), CHS (449-450)) (121-450)], (223-219')-disulfide with kappa light chain (1'-219') [V-KAPPA Musmus/Homsap (Mus musculus IGKV1-99*01 (92.0%) -IGKJ1*02 (90.0%) L124>V (109)/Homo sapiens IGKV2D-29*02 (88.0%) -IGKJ4*01 (91.7%), CDR-IMGT [11.3.9] (27-37.55-57.94-102)) (1'-112') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (158), V101 (196) (113'-219')]; dimer (229-229'':232-232'')-bisdisulfide, produced in a Chinese hamster ovary (CHO)-DG44 cell line, glycoform alfa
mazorelvimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MAZORELVIMAB

Synonyms and Mappings

Resources